Access to medicines
Countries must stop blocking and move toward formal negotiations on pandemic monopoly waiver at WTO
Press Release
9 Mar 2021
Too often we cannot treat patients because the medicines are too expensive, or they are no longer produced. Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure.
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases.